Medorekkusu
4586.TTSE GROWTHPharmaceutical
Filed as Medrx Co.,Ltd. (2022-08–2026-08)
Major holders (5%+) · 2
| Holder | Stake |
|---|---|
| Matsumura Yonehiro | 10.57% |
| Growth Capital Inc. | 6.15% |
Each holder's own ratio from its most recent large-shareholding report.
Former and minor holders (below 5%) · 3
| Long Corridor Asset Management Limited | 4.78% |
| Evo Fund | 4.22% |
| Evolution Capital Management LLC | 0.00% |
Ownership history · 59
| Holder | Ratio | Change |
|---|---|---|
| Long Corridor Asset Management Limited2025-06-05 · amended | 14.07% | -1.00pp |
| Long Corridor Asset Management Limited2025-05-20 · amended | 15.07% | -1.01pp |
| Long Corridor Asset Management Limited2025-04-30 | 16.08% | -3.91pp |
| Long Corridor Asset Management Limited2025-04-30 · amended | 19.99% | no change |
| Long Corridor Asset Management Limited2025-04-28 · amended | 19.99% | -0.73pp |
| Long Corridor Asset Management Limited2025-04-17 | 20.72% | new |
| Matsumura Yonehiro2024-06-10 · amended | 10.57% | new |
| Evolution Capital Management LLC2024-02-13 · amended | 0.00% | no change |
| Evo Fund2024-02-13 · amended | 4.33% | -1.12pp |
| Evolution Capital Management LLC2024-02-13 · amended | 0.00% | no change |
| Evo Fund2024-02-13 · amended | 5.45% | -1.08pp |
| Evolution Capital Management LLC2024-02-13 · amended | 0.00% | no change |
| Evo Fund2024-02-13 · amended | 6.53% | -0.96pp |
| Evolution Capital Management LLC2024-02-13 · amended | 0.00% | no change |
| Evo Fund2024-02-13 · amended | 7.49% | -1.33pp |
| Evolution Capital Management LLC2024-02-13 · amended | 0.00% | no change |
| Evo Fund2024-02-13 · amended | 8.82% | -1.14pp |
| Evolution Capital Management LLC2024-02-13 · amended | 0.00% | no change |
| Evo Fund2024-02-13 · amended | 9.96% | +0.50pp |
| Evolution Capital Management LLC2024-02-13 · amended | 0.00% | no change |
Each holder in 5% reports, joint holders included. Purpose is classified from the filed text.